This inventor holds 1 USPTO granted patent. Top assignee: Diramed, LLC. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Innovations of John M Rihl in Optical Blood Analysis
Introduction
John M Rihl is an accomplished inventor based in Fort Pierre, SD (US). He has made significant contributions to the field of medical technology, particularly in non-invasive blood analysis. His innovative approach has the potential to enhance patient care by providing accurate measurements of blood analytes without the need for invasive procedures.
Latest Patents
John M Rihl holds a patent for a "Zero corrected optical blood analyte detector." This invention is directed towards a method and apparatus for non-invasively measuring the concentration of an unknown blood analyte present in a patient. The method involves determining the concentration of a reference analyte present in the patient. Using the non-invasive optical instrument of the invention, the concentrations of both the reference analyte and the unknown analyte are measured. If the measured reference analyte concentration and the determined reference analyte concentration are substantially the same, then the measured unknown analyte concentration is displayed. Conversely, if the two concentrations are not substantially the same, an adjustment factor is applied to the measured unknown analyte concentration before displaying it.
Career Highlights
John M Rihl has dedicated his career to advancing medical technology through innovative inventions. His work at Diramed, LLC has positioned him as a key player in the development of non-invasive medical devices. His patent reflects his commitment to improving healthcare outcomes through technology.
Collaborations
John has collaborated with notable professionals in his field, including Robert P Schlegel and Steven V Ricca. These collaborations have contributed to the successful development and implementation of his innovative technologies.
Conclusion
John M Rihl's contributions to the field of optical blood analysis exemplify the impact of innovation in healthcare. His patented technology promises to revolutionize the way blood analytes are measured, ultimately benefiting patients and healthcare providers alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile